×

Subcutaneous Self-Administration Markets to 2022

Dublin, Dec. 10, 2014 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/jdmqx3/subcutaneous) has announced the addition of the "Subcutaneous Self-Administration Markets to 2022" report to their offering.

As healthcare markets continue to evolve, drug developers and their supply chain partners are attempting to keep pace by addressing economic, market and therapeutic factors that increasingly revolve around how, when and where drugs are administered. This evolution is being driven by new and exciting options for patient care in the form of powerful drug therapies for treating diseases with improved outcomes and for treating diseases for which an effective treatment did not previously exist.

Beyond oncology -where therapeutics continue to be supplied for administration via infusion - the majority of new non-oral drugs are being formulated for subcutaneous injection. Many of these drugs are indicated for chronic conditions, which because of the continuous need for dosing over time benefit significantly when patients can self-administer their medication. This report examines in detail the drugs, devices, therapeutics and markets that are set to change substantially over the remainder of the decade.


Key Topics Covered:

1. Executive Summary

2. Subcutaneous Drug Delivery - Market Dynamics

  • Subcutaneous Delivery - Why it's Growing
  • The Evolving Drug Pipeline
  • Device and Packaging Technology Advances
  • Shifting Patient Demographics
  • Healthcare Economics
  • Demand Drivers
  • The Trend toward Self-Administration
  • Innovation in Prefilled Device Designs
  • Therapeutic Targets and Treatment
  • Competitive Landscape
  • Risk Factors

3. SC Delivery Device Design Factors

  • Ergonomics and Ease of Use
  • Safety Features
  • Needle Shielding
  • Needle Insertion Depth
  • Failsafe Activation
  • Dose Inspection/Injection Confirmation
  • Lyophilized Drugs/Reconstitution

4. Subcutaneously Delivered Drugs - Delivery Device Strategies

  • Delivering Self-Administered SC Drugs
  • Handheld Devices
  • Autoinjectors
  • Pen Injectors
  • Prefilled Syringes
  • Other Handheld Devices
  • Wearable Devices
  • Patch Pumps
  • Large Volume Wearable Devices

5. SC Self-Administration - Product Analysis & Forecasts by Therapeutic Sector

  • Anticoagulants
  • Antivirals
  • Autoimmune Diseases
  • Diabetes
  • Hematopoietics
  • Hormone Replacement
  • Neurology
  • Osteoporosis
  • Reproductive Health

6. Market Factors

  • Regulatory Issues
  • DTC Marketing
  • Patient Education

7. Company Profiles

For more information visit http://www.researchandmarkets.com/research/jdmqx3/subcutaneous


CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Pharmaceuticals, Drug Delivery

Source:Research and Markets